NPI: 1730758806 · ORLANDO, FL 32835 · Pediatrics Physician · NPI assigned 06/22/2021
Authorized official BRIDGES, ROBERT controls 18+ related entities in our dataset. Read more
| Authorized Official | BRIDGES, ROBERT (EVP, OPERATIONS) |
| Parent Organization | CHILDREN'S HEALTH ALLIANCE, LLC |
| NPI Enumeration Date | 06/22/2021 |
Other providers sharing the same authorized official: BRIDGES, ROBERT
| Year | Claims | Total Paid |
|---|---|---|
| 2021 | 1,300 | $57K |
| 2022 | 5,516 | $312K |
| 2023 | 5,980 | $299K |
| 2024 | 2,572 | $145K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2,290 | 2,107 | $241K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3,258 | 2,992 | $197K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 987 | 896 | $100K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 774 | 725 | $81K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1,603 | 1,452 | $75K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 491 | 443 | $40K |
| 90461 | 940 | 809 | $24K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 181 | 166 | $20K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 480 | 448 | $7K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 39 | 37 | $5K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 303 | 295 | $4K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 62 | 60 | $3K |
| 99177 | 549 | 517 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 27 | 27 | $2K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 24 | 24 | $2K |
| 90651 | 55 | 54 | $2K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 13 | 13 | $2K |
| 90686 | 523 | 514 | $2K | |
| 85018 | 543 | 466 | $750.77 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 275 | 234 | $421.44 |
| 83655 | 73 | 55 | $385.65 | |
| 90710 | 14 | 13 | $314.56 | |
| 99188 | 14 | 14 | $289.67 | |
| 36416 | 758 | 694 | $198.00 | |
| 90670 | 239 | 232 | $147.74 | |
| 80061 | Lipid panel | 22 | 15 | $107.09 |
| 90674 | 43 | 39 | $82.00 | |
| 96127 | 102 | 65 | $60.19 | |
| 90633 | 66 | 65 | $32.50 | |
| 90647 | 165 | 158 | $32.00 | |
| 90680 | 92 | 91 | $0.00 | |
| 90723 | 121 | 119 | $0.00 | |
| 92551 | 160 | 114 | $0.00 | |
| 90656 | 16 | 16 | $0.00 | |
| 90696 | 14 | 13 | $0.00 | |
| 99173 | 52 | 30 | $0.00 |